NexImmune, Inc.
NEXI · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $3,561 | $6,978 | $2,367 | $5,501 |
| - Cash | $2,424 | $4,473 | $3,202 | $9,000 |
| + Debt | $0 | $0 | $69 | $605 |
| Enterprise Value | $1,137 | $2,505 | -$766 | -$2,894 |
| Revenue | $0 | $0 | $2,121 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$75 | -$115 | $1,892 | -$266 |
| % Margin | – | – | 89.2% | – |
| EBITDA | -$2,654 | -$2,643 | -$5,130 | -$7,625 |
| % Margin | – | – | -241.9% | – |
| Net Income | -$2,327 | -$3,077 | -$5,359 | -$9,854 |
| % Margin | – | – | -252.7% | – |
| EPS Diluted | -1.69 | -2.46 | -5.03 | -9.4 |
| % Growth | 31.3% | 51.1% | 46.5% | – |
| Operating Cash Flow | -$2,072 | -$2,416 | -$5,833 | -$7,284 |
| Capital Expenditures | $0 | $0 | -$48,671 | -$1 |
| Free Cash Flow | -$2,072 | -$2,416 | -$54,504 | -$7,285 |